Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Sep 16;116(11):1994-5.
doi: 10.1182/blood-2010-06-289819.

Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm

Hélène Peyro-Saint-Paul, Fabienne Hermitte
Comment

Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm

Hélène Peyro-Saint-Paul et al. Blood. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Warshawsky I, Mularo F, Hren C, Jakubowski M. Failure of the Ipsogen MutaScreen kit to detect the JAK2 617V>F mutation in samples with additional rare exon 14 mutations: implications for clinical testing and report of a novel 618C>F mutation in addition to 617V>F [letter]. Blood. 2010;115(15):3175–3176. - PubMed
    1. Murugesan G, Aboudola S, Szpurka H, et al. Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis. Am J Clin Pathol. 2006;125(4):625–633. - PubMed
    1. Biglia O, le Couedic J, Hermouet S, Hermitte F, Maroc N. Development and validation of new molecular diagnostic assays for the JAK2 V617F screening and quantification [abstract]. Association for Molecular Pathology 2007 Annual Meeting Abstracts. J Mol Diagn. 2007;9:669. Abstract H633.
    1. Cankovic M, Whiteley L, Hawley RC, Zarbo RJ, Chitale D. Clinical performance of JAK2 V617F mutation detection assays in a molecular diagnostics laboratory: evaluation of screening and quantitation methods. Am J Clin Pathol. 2009;132(5):713–721. - PubMed
    1. Ma W, Kantarjian H, Zhang X, et al. Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias. J Mol Diagn. 2009;11(1):49–53. - PMC - PubMed

MeSH terms